Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Peer

Showing results (31-40 of 181) with videos related to

Pageof 19
Sort By:
Trends in Pharmacological Sciences|September 7, 2020
Paving the Road for RNA TherapeuticsNiels Dammes, Dan Peer
Advanced Drug Delivery Reviews|August 4, 2019
Reprogramming the lymphocyte axis for advanced immunotherapyS Moein Moghimi, Dan Peer
Nanotechnology|November 30, 2017
Focus on RNA interference: from nanoformulations to in vivo deliveryJeffery M Karp, Dan Peer
Chemistry and Physics of Lipids|April 3, 2012
Liposomes, lipid biophysics, and sphingolipid research: from basic to translation researchYechezkel Chezy Barenholz, Dan Peer
Drug Delivery and Translational Research|March 20, 2015
RNA interference-based therapeutics and diagnosticsDan Peer, Kenneth A Howard
Current Opinion in Biotechnology|January 17, 2016
RNA nanomedicines: the next generation drugs?Manu Smriti Singh, Dan Peer
Therapeutic Delivery|January 16, 2016
siRNA delivery: current trends and future perspectivesManu Smriti Singh, Dan Peer
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 11, 2012
Altering the immune response with lipid-based nanoparticlesDalit Landesman-Milo, Dan Peer
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
Orchestrating a Symphony on a Single Conjugate: Aptamer Targeting, Gene Silencing, and Immunomodulation to Enhance Antitumor ResponseBrandon D Ng, Dan Peer
Drug Delivery and Translational Research|March 20, 2015
Toxicity profiling of several common RNAi-based nanomedicines: a comparative studyDalit Landesman-Milo, Dan Peer
Pageof 19

Showing results (31-40 of 181) with videos related to

Sort By:
Pageof 19
Trends in Pharmacological Sciences|September 7, 2020
Paving the Road for RNA TherapeuticsNiels Dammes, Dan Peer
Advanced Drug Delivery Reviews|August 4, 2019
Reprogramming the lymphocyte axis for advanced immunotherapyS Moein Moghimi, Dan Peer
Nanotechnology|November 30, 2017
Focus on RNA interference: from nanoformulations to in vivo deliveryJeffery M Karp, Dan Peer
Chemistry and Physics of Lipids|April 3, 2012
Liposomes, lipid biophysics, and sphingolipid research: from basic to translation researchYechezkel Chezy Barenholz, Dan Peer
Drug Delivery and Translational Research|March 20, 2015
RNA interference-based therapeutics and diagnosticsDan Peer, Kenneth A Howard
Current Opinion in Biotechnology|January 17, 2016
RNA nanomedicines: the next generation drugs?Manu Smriti Singh, Dan Peer
Therapeutic Delivery|January 16, 2016
siRNA delivery: current trends and future perspectivesManu Smriti Singh, Dan Peer
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 11, 2012
Altering the immune response with lipid-based nanoparticlesDalit Landesman-Milo, Dan Peer
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
Orchestrating a Symphony on a Single Conjugate: Aptamer Targeting, Gene Silencing, and Immunomodulation to Enhance Antitumor ResponseBrandon D Ng, Dan Peer
Drug Delivery and Translational Research|March 20, 2015
Toxicity profiling of several common RNAi-based nanomedicines: a comparative studyDalit Landesman-Milo, Dan Peer
Pageof 19